Weight loss study for adults in Asia
Part of Hormones & metabolism clinical trials.
This study tests an investigational medicine called Zenagamtide to see if it helps people with excess body weight lose weight. It is specifically for adults in Asia who do not have diabetes and have not taken certain weight-loss or diabetes medicines before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must not have type 1 or type 2 diabetes.
- You must not have taken diabetes or weight-loss medicines like Ozempic, Wegovy, or similar drugs before.
- You must be living in Asia (the study is for people in Asia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
This study tests an investigational weight-loss medicine called Zenagamtide for people who have heart or blood vessel disease and are overweight or obese. The goal is to see if it can reduce heart-related risks compared to a placebo (a pill with no active medicine).
This study tests how the timing of your meal and how much water you drink with the medicine affect how your body absorbs a new medicine called Zenagamtide. If you have overweight or obesity, this could help find the best way to take the medicine for maximum effect.
This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.
This study tests how well adults with overweight or obesity, with or without type 2 diabetes, tolerate switching from their current weight-loss medication (tirzepatide) to a new medicine called zenagamtide. It may help you understand if this new option is easier on your stomach.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.